Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aura Biosciences, Inc. (AURA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,210,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aura Biosciences is a clinical-stage biotechnology company using its targeted oncology platform to develop a potential new standard of care across various cancer indications, with an initial focus on ocular and urologic oncology. Co.'s proprietary platform enables the targeting of a range of solid tumors using Virus-Like Particles that can be conjugated with drugs or loaded with nucleic acids to create Virus-Like Drug Conjugates (VDC). AU-011, Co.'s VDC candidate, is being developed for the first line treatment of primary choroidal melanoma. In addition, Co. is developing AU-011 for the treatment of non-muscle invasive bladder cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,759,601 1,779,667 3,045,667
Total Buy Value $0 $15,474,987 $15,643,162 $30,826,673
Total People Bought 0 2 2 2
Total Buy Transactions 0 5 7 12
Total Shares Sold 0 33,811 46,782 57,290
Total Sell Value $0 $308,327 $396,896 $527,771
Total People Sold 0 2 2 4
Total Sell Transactions 0 4 6 10
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 45
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kilroy Conor General Counsel and Secretary   •       –      –    2024-04-02 4 A $0.00 $0 D/D 96,000 96,000     -
   Plavsic Mark Chief Technology Officer   •       –      –    2024-03-15 3 IO $0.00 $0 D/D 0 128,515     -
   De Los Pinos Elisabet See Remarks   •       •      –    2024-02-01 4 A $0.00 $0 D/D 162,935 324,373     -
   Hopkins Janet Jill Chief Medical Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 28,515 163,515     -
   Feder Julie B Chief Financial Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 71,285 134,276     -
   Feder Julie B Chief Financial Officer   •       –      –    2024-01-23 4 S $7.64 $50,521 D/D (6,609) 62,991     -
   De Los Pinos Elisabet See Remarks   •       •      –    2024-01-23 4 S $7.64 $121,141 D/D (15,853) 161,438     -
   Goel David E. 10% Owner   –       –       •   2023-11-09 4 B $9.00 $14,040,000 I/I 1,560,000 6,922,870 1.5     -
   Johnson David Michael   –       •      –    2023-11-08 4 B $7.30 $146,000 I/I 20,000 75,000 0.01     -
   Johnson David Michael   –       •      –    2023-11-08 4 B $7.30 $70,087 D/D 9,601 135,667 0.01     -
   Johnson David Michael   –       •      –    2023-11-07 4 B $7.17 $673,980 I/I 94,000 65,000 0.01     -
   Johnson David Michael   –       •      –    2023-11-07 4 B $7.17 $544,920 D/D 76,000 126,066 0.01     -
   De Los Pinos Elisabet See Remarks   •       •      –    2023-11-06 4 AS $12.03 $89,611 D/D (7,449) 177,291     -
   De Los Pinos Elisabet See Remarks   •       •      –    2023-11-06 4 OE $2.74 $10,412 D/D 3,800 184,740     -
   Feder Julie B Chief Financial Officer   •       –      –    2023-11-06 4 AS $12.07 $47,054 D/D (3,900) 69,600     -
   Feder Julie B Chief Financial Officer   •       –      –    2023-11-06 4 OE $2.74 $10,686 D/D 3,900 73,500     -
   De Los Pinos Elisabet See Remarks   •       •      –    2023-10-30 4 S $6.83 $65,478 D/D (9,586) 180,940     -
   Feder Julie B Chief Financial Officer   •       –      –    2023-10-30 4 S $6.82 $23,091 D/D (3,385) 69,600     -
   Johnson David Michael   –       •      –    2023-10-04 4 B $8.61 $56,512 D/D 6,566 50,066 0.01     -
   Johnson David Michael   –       •      –    2023-10-03 4 B $8.27 $111,663 D/D 13,500 43,500 0.01     -
   De Rosch Mark Chief Operating Officer   •       –      –    2023-01-19 4 A $0.00 $0 D/D 42,250 58,635     -
   Rich Cadmus See Remarks   •       –      –    2023-01-19 4 A $0.00 $0 D/D 34,125 58,703     -
   De Los Pinos Elisabet See Remarks   •       •      –    2023-01-19 4 A $0.00 $0 D/D 121,875 190,526     -
   Feder Julie B Chief Financial Officer   •       –      –    2023-01-19 4 A $0.00 $0 D/D 48,750 72,985     -
   Johnson David Michael Director   –       •      –    2023-01-06 4 B $10.50 $16,851 I/I 1,604 18,000 2.1     -
  45 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us